Future of 'AI doctors': Doctronic co-founders on the rise of AI prescriptions

Summary

Doctronic co-founders Dr. Adam Oskowitz and Matt Pavelle discuss their AI doctor platform on Squawk Box. They explain how their Utah program can renew low-risk prescriptions without a human in the loop, using a 200-drug formulary and human escalation for safety. They also discuss primary-care bottlenecks, $100 billion in annual medication noncompliance costs, and their $4 per renewal business model.

• Doctronic has handled 20 million AI patient consultations and runs a 24/7 licensed primary care practice.
• Utah's program allows AI to renew about 200 low-risk medications without human involvement.
• The AI escalates unsafe refill requests to human doctors and uses about a dozen non-AI guardrails.
• Founders cite 26-day waits for primary care and $100 billion annual medication noncompliance as key problems.
• Doctronic charges $4 per AI renewal and says AI is expensive to develop but cheap to run.
• The discussion covers physician revenue incentives, rural access, and patient cost barriers.